BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9137083)

  • 1. Analysis of estrogen receptor messenger RNA in breast carcinomas from archival specimens is predictive of tumor biology.
    Carmeci C; deConinck EC; Lawton T; Bloch DA; Weigel RJ
    Am J Pathol; 1997 May; 150(5):1563-70. PubMed ID: 9137083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction.
    Iwao K; Miyoshi Y; Egawa C; Ikeda N; Tsukamoto F; Noguchi S
    Cancer; 2000 Oct; 89(8):1732-8. PubMed ID: 11042568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor-alpha mRNA in primary breast cancer: relationship to estrogen and progesterone receptor proteins and other prognostic factors.
    Chearskul S; Bhothisuwan K; Churintrapun M; Semprasert N; Onreabroi S
    Asian Pac J Allergy Immunol; 2002 Mar; 20(1):13-21. PubMed ID: 12125913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
    Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H
    Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype.
    Carmeci C; Thompson DA; Kuang WW; Lightdale N; Furthmayr H; Weigel RJ
    Surgery; 1998 Aug; 124(2):211-7. PubMed ID: 9706140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.
    Moinfar F; Okcu M; Tsybrovskyy O; Regitnig P; Lax SF; Weybora W; Ratschek M; Tavassoli FA; Denk H
    Cancer; 2003 Aug; 98(4):703-11. PubMed ID: 12910513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression.
    Dotzlaw H; Miller T; Karvelas J; Murphy LC
    Cancer Res; 1990 Jul; 50(14):4204-8. PubMed ID: 2364377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells.
    deFazio A; Chiew YE; McEvoy M; Watts CK; Sutherland RL
    Cell Growth Differ; 1997 Aug; 8(8):903-11. PubMed ID: 9269899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of expression of a 55 kDa nuclear protein (nmt55) in estrogen receptor-negative human breast cancer.
    Traish AM; Huang YH; Ashba J; Pronovost M; Pavao M; McAneny DB; Moreland RB
    Diagn Mol Pathol; 1997 Aug; 6(4):209-21. PubMed ID: 9360842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of estrogen receptor variant messenger RNAs in human breast cancer.
    Leygue E; Huang A; Murphy LC; Watson PH
    Cancer Res; 1996 Oct; 56(19):4324-7. PubMed ID: 8813116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P
    Breast J; 2005; 11(4):278-80. PubMed ID: 15982396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies: a multi-institutional retrospective study using tissue microarrays.
    Bae YK; Gong G; Kang J; Lee A; Cho EY; Lee JS; Suh KS; Lee DW
    Am J Surg Pathol; 2012 Dec; 36(12):1817-25. PubMed ID: 23154769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.
    Zhang Z; Yamashita H; Toyama T; Omoto Y; Sugiura H; Hara Y; Wu X; Kobayashi S; Iwase H
    Breast Cancer Res; 2003; 5(6):R250-6. PubMed ID: 14580261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
    Kok M; Linn SC; Van Laar RK; Jansen MP; van den Berg TM; Delahaye LJ; Glas AM; Peterse JL; Hauptmann M; Foekens JA; Klijn JG; Wessels LF; Van't Veer LJ; Berns EM
    Breast Cancer Res Treat; 2009 Jan; 113(2):275-83. PubMed ID: 18311582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a repressor of estrogen receptor activity in human breast tumors: relationship to some known prognostic markers.
    Simon SL; Parkes A; Leygue E; Dotzlaw H; Snell L; Troup S; Adeyinka A; Watson PH; Murphy LC
    Cancer Res; 2000 Jun; 60(11):2796-9. PubMed ID: 10850416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer.
    Huang A; Leygue ER; Snell L; Murphy LC; Watson PH
    Am J Pathol; 1997 May; 150(5):1827-33. PubMed ID: 9137105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polo-like kinase: a novel marker of proliferation: correlation with estrogen-receptor expression in human breast cancer.
    Wolf G; Hildenbrand R; Schwar C; Grobholz R; Kaufmann M; Stutte HJ; Strebhardt K; Bleyl U
    Pathol Res Pract; 2000; 196(11):753-9. PubMed ID: 11186170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.